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Abstract
The genetic background of apolipoprotein E (apoE) deficient mice influences atherosclerot-
ic plaque development. We previously reported three quantitative trait loci (QTL), Aath1–
Aath3, that affect aortic arch atherosclerosis independently of those in the aortic root in a
cross between C57BL6 apoEKOmice (B6-apoE) and 129S6 apoEKOmice (129-apoE). To
gain further insight into genetic factors that influence atherosclerosis at different vascular lo-
cations, we analyzed 335 F2 mice from an intercross between 129-apoE and apoEKOmice
on a DBA/2J genetic background (DBA-apoE). The extent of atherosclerosis in the aortic
arch was very similar in the two parental strains. Nevertheless, a genome-wide scan identi-
fied two significant QTL for plaque size in the aortic arch: Aath4 on Chromosome (Chr) 2 at
137 Mb and Aath5 on Chr 10 at 51 Mb. The DBA alleles of Aath4 and Aath5 respectively
confer susceptibility and resistance to aortic arch atherosclerosis over 129 alleles. Both
QTL are also independent of those affecting plaque size at the aortic root. Genome analysis
suggests that athero-susceptibility of Aath4 in DBA may be contributed by multiple genes,
includingMertk and Cd93, that play roles in phagocytosis of apoptotic cells and modulate
inflammation. A candidate gene for Aath5 is Stab2, the DBA allele of which is associated
with 10 times higher plasma hyaluronan than the 129 allele. Overall, our identification of two
new QTL that affect atherosclerosis in an aortic arch-specific manner further supports the
involvement of distinct pathological processes at different vascular locations.
Introduction
Atherosclerosis is a systemic disease that involves multiple vascular bed, and leads to regional
clinical manifestations, including stroke, myocardial infarction, abdominal aortic aneurysm,
renal failure, and peripheral arterial diseases. Since multiple risk factors such as dyslipidemia and
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environmental determinants including diet are common to all vascular locations, it is not surpris-
ing that the severity of atherosclerosis in human patients shows a strong concordance between
one location and another [1]. Nevertheless, risk factor profiles for these locations can be distinct.
For example, smoking selectively increased the risk of plaques in the abdominal aorta without
influencing right coronary artery lesions in 25–34 age groups [1]. Diabetes significantly increased
the risk of plaques in the lower limbs, while the risk of atherosclerosis in the carotid artery was in-
creased in hypertensive patients [2]. These heterogeneities raise the possibility that plaque devel-
opment at different vascular locations involves distinct pathological processes [3].
A meta-analysis using compiled data of genome wide association studies (GWAS) from a
large number of human subjects found the strongest association between coronary artery dis-
ease (CAD) and an intergenic region at chromosome 9p21, a region where only a non-coding
RNA of unknown function (ANRIL) is located [4,5]. All the loci discovered so far have relative-
ly modest effects with odds ratios<1.3, supporting the notion that CAD is generally due to
“many little things” [6]. Interestingly, a majority of genes identified by a different meta-analysis
of GWAS data for carotid intima/media thickness and plaque size, which are measures of sub-
clinical atherosclerosis, were not the same as those identified by the GWAS for CAD [7]. The
lack of overlapping factors between these two studies is multifactorial and could involve a com-
bination of different clinical stages of atherosclerosis, and/or different genetic factors affecting
the development of lesions at the two anatomical locations.
Established mouse models of atherosclerosis, such as apolipoprotein E knockout (Apoe-/-,
apoEKO) and lipoprotein receptor knockout (Ldlr-/-) mice are on a C57BL6/J genetic back-
ground. In these mice, plaques develop first at the aortic root near the attachment sites of the
aortic valves, a location where plaques are relatively uncommon in humans. Plaques at other
locations throughout the aorta develop only as the mice age [8]. In contrast, we found that
apoEKO mice on a 129S6 genetic background (129-apoE) differ from the apoEKO mice on a
C57BL/6 background (B6-apoE) in atherosclerotic plaque development in a location-specific
manner [9]. Plaque development at the aortic root of 129-apoE mice is slower than in B6-apoE
mice. In marked contrast, however, the 129-apoE mice develop extensive plaques in the aortic
arch much earlier than B6-apoE mice. Our subsequent quantitative trait loci (QTL) mapping
of an F2 population of a cross between these apoEKO strains has detected two peaks (Aath1
and Aath2) on Chr 1, and one peak on Chr 15 (Aath3), which influence the susceptibility of
the aortic arch to develop lesions [10]. These three regions were distinct from QTL regions that
influence aortic root plaque size, suggesting that different genetic factors are likely contributing
to the strain- and location-specific differences of plaque development.
In the present study, we have carried out QTL analysis of atherosclerotic plaque size at the
aortic arch in the F2 population derived from an intercross between apoEKO mice on a DBA/
2J background (DBA-apoE) and those on a 129S6 background (129-apoE). We found that the
loci affecting plaque size at the aortic arch between these two strains are distinct from those af-
fecting the plaque size at their aortic root, which we reported recently [11]. With the use of ge-
nomic information on C57BL/6J, 129S5 and DBA/2J strains, and gene expression analysis of
the aortic arch and peritoneal macrophage of the parental strains, we identify factors that influ-
ence early atherosclerotic plaque development in the aortic arch.
Results
Atherosclerotic plaque size in the aortic arch of parental, F1, and F2
apoEKOmice
Atherosclerotic plaque size in the aortic arch and its branches was measured in parental 129-
apoE and DBA-apoE, F1, and F2 mice as previously described (Table 1 and S1 Table) [10].
QTL for Early Atherosclerosis in Mouse Aortic Arch
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Although apoEKO mice on a DBA background develop 10 times larger plaques at their aortic
root than 129-apoE mice [11], average plaque size in the aortic arch was comparable between
the two strains in both males and females. In the following analysis, we used square root- trans-
formed lesion size, which showed a normal distribution (Fig. 1A and S2 Table). A positive cor-
relation between lesion size at the aortic arch and at the aortic root in individual F2 animals
(r2 = 0.07, P< 0.001) indicates that approximately 7% of the variance of plaque size at these
two sites can be explained by common factors in sex-combined analysis (Fig. 1B). As shown in
Fig. 1C and 1D, the correlation was weak in males (r2 = 0.05, P< 0.01), but was stronger in fe-
males (r2 = 0.14, P< 0.001). We observed large variations in the body weight of F2 progeny
(S1A Fig.), which are weakly but positively correlated with aortic arch lesion sizes, explaining
Table 1. Atherosclerotic plaque size at the aortic arch area in the parental, F1, and F2 mice.
129-apoE (n) DBA-apoE (n) F1 (n) F2 (n)
Male 129.9 ± 26.3 (15) 133.0 ± 27.1 (16) 124.1 ± 33.2 (14) 121.0 ± 40.8 (191)
Female 112.7 ± 27.6 (17)† 129.3 ± 24.2 (16) 108.7 ± 26.3 (8) 112.5 ± 38.4 (144)
Data are shown as the mean ± SD (× 104 μm2). †P < 0.05 vs. male mice within the strain.
doi:10.1371/journal.pone.0117478.t001
Fig 1. Distributions of the arch plaque size and correlations between the arch and the root plaques. (A) Histograms of square root-transformed
atherosclerotic plaque size at the aortic arch in 335 F2 mice derived from 129-apoE and DBA-apoEmice. Arrows represent the positions of average plaque
size for parental 129-apoE, DBA-apoE and F1 mice. (B–C) Correlations between arch and root plaque size in males and females (A), males (B), and females
(C).
doi:10.1371/journal.pone.0117478.g001
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approximately 3% of the variation of arch lesion (S1B and C Fig.). No correlation was found
between body weight and root lesion (S1D and E Fig.). Hypercholesterolemia is common to
both strains, but the plasma lipid levels were not strong determinants of the size of aortic arch
plaques (S2 Fig.).
QTL analysis
We performed genome-wide single scans for QTL that influence atherosclerotic plaque size (in
square root) in the aortic arch and its branches using 170 SNP genotypes of 191 F2 males and
144 F2 females (Fig. 2 and S3 Fig., Table 2 and S3 Table). To account for potential gender dif-
ferences and interactions, the genome scans were performed in both sexes combined using sex
as an additive or interactive covariate, or separately in males and females.
Two significant QTL for aortic arch lesion size were detected in the sex-combined analysis;
one on Chr 2 (LOD = 7.0, 137 Mb, CI: 123–148 Mb) and the other on Chr 10 (LOD = 5.1, 51
Mb, CI: 30–101 Mb), which we name Aath4 and Aath5 respectively (Fig. 2A and Table 2). No
significant differences were observed between the sex-additive and sex-interactive analyses.
When two sexes were analyzed separately, the male-only analysis revealed two significant loci;
one on Chr 2 (LOD = 4.0, 153 Mb) and the other on Chr 10 (LOD = 4.0, 46 Mb), and one sug-
gestive locus on Chr 19 (LOD = 3.1, 43 Mb). In the female-only analysis, one suggestive QTL
on Chr 2 (LOD = 3.3, 132 Mb) was detected (Fig. 2B and Table 2). The shape of LOD curves
raised a possibility that multiple QTL might be present on Chr 2 (Fig. 2C) and Chr 10
(Fig. 2D). To search for a potential second QTL on these chromosomes, we calculated LOD
score differences between the one-QTL and two-QTL models (ΔLOD) for each chromosome.
The presence of an additional QTL was indicated on Chr 2 (ΔLOD = 2.3), while the evidence
for a second QTL on Chr 10 was weak (ΔLOD = 1.3). To establish the relative contribution of
each locus, we performed multiple regression analyses of all the detected loci together. Aath4
and Aath5 explained 10.7% and 5.8% of the variation in the arch lesion, respectively (S4
Table). The DBA-allele of Aath4 on Chr 2 was associated with an increased arch plaque size
over the 129-allele, while at Aath5 on Chr 10, the 129-allele conferred increased arch plaque
size relative to the DBA-allele (Fig. 3).
QTL for complex diseases such as atherosclerosis likely have epistatic interactions between
loci. We therefore carried out genome-wide scans allowing for a pair-wise analysis to search for
additional QTL and interactions between loci. No additional interacting loci were observed.
Haplotype analysis and overlap with human GWAS
Aath4 for aortic arch plaques was detected at Chr 2: 137 Mb (CI: 123–148 Mb) in the current
DBA-apoE × 129-apoE intercross but was not present in the previous B6-apoE ×129-apoE
cross [10]. Since neither pair-wise scan nor multiple regression analysis suggested interactions
of Aath4 with any other chromosomal loci, the simplest inference is that Aath4 lies within re-
gions where the sequence of 129 mice differs from that of DBA mice, but is shared with that
of the B6 mice. Fig. 4A illustrates the pattern of single nucleotide polymorphism (SNP) dis-
tribution in the region of Chr 2 using Mouse Phylogeny Viewer. Regions colored orange,
where DBA differs from 129 and B6 and Aath4 likely locates, are at 125–129 Mb, 131 Mb,
135 Mb, 139–143 Mb and 148–149 Mb. These regions correspond to Chr 15q21, 2q11–14
and 20p11–13 in humans, each of which contains variations associated with cardiovascular
phenotypes. For example in Chr 15q21, variations in FBN1 are associated with aortic aneurysm
(P = 6.0 × 10-13), SNPs in or near SHC4 are related to plasma apoE concentrations (P = 3.6 × 10-9),
and an intronic SNPs in ATP8B4 andHDC are associated with coronary disease and stroke
(P = 5.6 × 10-5 and P = 1.3 × 10-4, respectively). In Chr 2q11–14, a SNP in an intron of Bcl2l11
QTL for Early Atherosclerosis in Mouse Aortic Arch
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Fig 2. LOD curves for atherosclerotic plaque size at the arch. (A) LOD curves for the arch lesion with sex as an additive covariate (black line) and as an
interactive covariate (red line). X-axis represents chromosome number and y-axis represents the LOD score. The horizontal dashed lines represent the
thresholds for significant QTL (P = 0.05) and suggestive QTL (P = 0.63) in the sex-interactive model. (B) LOD curves for arch lesion in males (blue line) and
females (red line). The horizontal dashed lines represent the thresholds for significant QTL (P = 0.05) in males (blue) and females (red). (C and D) LOD
curves for the arch lesion on Chr 2 (C) and Chr 10 (D) with sex as an interactive covariate (black), in males (blue) and in females (red). X-axis represents
positions on chromosome (cM) and y-axis represents the LOD score.
doi:10.1371/journal.pone.0117478.g002
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is related to coronary disease (P = 6.1 × 10-5). In Chr 20p11–13, a SNP in RNF24 is associated
with blood pressure (P = 4.0 × 10-6), PLCB4 with leukocyte counts (P = 3.0 × 10-10), and
PCSK2 with carotid artery intimal medial thickness (P = 3.4 × 10-6).
Aath5 is on Chr 10 at 51 Mb with a broad confidence interval of 30–101 Mb. Like Aath4,
Aath5most likely lies within the regions where the DNA sequence of 129 mice differs from
Table 2. QTL for atherosclerosis at the aortic arch identified by genome-wide single scan.
Chr Peak (cM) CI (cM) Peak (Mb) CI (Mb) LOD Significance High Allele Mode of Inheritance
Female and Male 2 68 61–73 137 123–148 7.0 Significant DBA Additive
10 26 17–52 51 30–101 5.1 Significant 129 Additive
19 34 17–39 39 22–46 3.2 Suggestive 129 Recessive
Male 2 65 58–74 153 132–165 4.0 Significant DBA Additive
10 22 12–53 46 26–111 4.0 Significant 129 Additive
19 33 16–39 43 25–48 3.1 Suggestive 129 Recessive
Female 2 72 36–74 132 51–134 3.3 Suggestive DBA Additive
Model of inheritance was determined according to allelic effect at the nearest marker of a QTL by performing linear regression using the additive and
dominant/recessive models. Significant QTL are shown in bold letters. CI, 95% confidence interval.
doi:10.1371/journal.pone.0117478.t002
Fig 3. Allelic effects of QTL for atherosclerosis. Allelic distributions of the main effect QTL for arch plaques at the nearest makers to the peaks in Chr 2
and Chr 10. Atherosclerotic plaque size is indicated in square root (sqrt). Data represent the mean ± SD.
doi:10.1371/journal.pone.0117478.g003
QTL for Early Atherosclerosis in Mouse Aortic Arch
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that of DBA mice, but is shared with that of the B6 mice. Haplotype comparison (Fig. 4B)
shows that 129S6 and DBA/2J strains share a large portion of the Aath5 regions on Chr 10. Re-
gions where DBA/2J sequence differs from both 129S6 and B6 occur in four intervals: near 46
Mb, near 55 Mb, between 67.5 Mb and 69 Mb, and 84 Mb–93 Mb. These intervals correspond
to human Chr 6q21–22, Chr 10q21 and Chr 12q23–24. In Chr 6q21–22, SNPs near AIM1–ATG5
are associated with stroke (P = 9.2 × 10-6) and plasma VLDL concentration (P = 4.7× 10-7),
those near DCBLD1 are associated with carotid artery disease (P = 7.4 × 10-8), and a SNP in
SLC35F1 is associated with heart rate (P = 4.0 × 10-10). In Chr 10q21, variations in JMJD1C
are related to platelet count (P = 2.0 × 10-24), those in ARID5B with leukemia (P = 7.0 × 10-19),
and those in C10orf107 with blood pressure (P = 2.0 × 10-18). In Chr 12q23, variations near or
within STAB2 are associated with coronary restenosis (P = 1.0 × 10-7) [12], coronary disease
(P = 1.0 × 10-5) and stroke (P = 5.4 × 10-4), and those near IGF1 are associated with insulin
Fig 4. Haplotype comparison. Chromosome maps of Aath4 on Chr 2 (A) and Aath5 on Chr 10 (B) from UNCMouse Phylogeny Viewer. 129 sequences and
B6/DBA regions identical to 129 are shown in green; B6 sequences different from 129, and DBA sequences identical to B6 but not to 129 are shown in
purple; DBA-specific sequences are shown in orange. Arrows below indicate the position of representative candidate genes. Homologous human
chromosomal regions are derived from the Virtual Comparative Map (VCMap) tool. Human disease-associated regions are indicated above the human
chromosomal regions.
doi:10.1371/journal.pone.0117478.g004
QTL for Early Atherosclerosis in Mouse Aortic Arch
PLOS ONE | DOI:10.1371/journal.pone.0117478 February 17, 2015 7 / 22
resistance (P = 2.0 × 10-9). Additionally, an intronic SNP in UTP20 was associated with coro-
nary artery calcification in the Framingham Heart Study (P = 7.0 × 10-6) [13].
These associations indicate that human chromosomal regions equivalent to both the Aath4
and Aath5 loci contain candidate genes with therapeutic and translational potential in human
CVD and provide support for the presence of susceptible genes for atherosclerosis in the aortic
arch of mice.
Functional SNPs in the Aath4 interval
To gain insight into candidate genes underlying each QTL, we considered single nucleotide
polymorphisms (SNPs) and insertion/deletions that differ between DBA/2J and 129S5, the
closest relative to 129S6 (see methods section). On the basis that SNPs are directly or by linkage
responsible for the function and/or expression level of gene products, we examined potential
functional consequences of these SNPs. We placed primary emphasis on SNPs that are shared
by 129 and B6.
We first examined nonsynonymous SNPs with potentially damaging effects on protein
structure and functions by SHIFT [14] and Polyphen-2 [15] prediction programs (S5 Table).
Both programs predict a D492N substitution in fibrillin 1 (coded by Fbn1) to be potentially del-
eterious. Asp-492 is in one of the conserved EGF-like domains and may be involved in Ca2+
binding and/or growth factor binding to Fbn1, which is essential for the elastic fiber formation
in aortic tissue, and mutations to which cause Marfan syndrome [16]. Similarly, a N264H sub-
stitution in one of the EGF-like domains of Cd93 was also predicted to be deleterious. However,
the functional relevance of many other substitutions including D206Y in selenocysteine bind-
ing protein 2-like (Secisbp2l), E33G in DTW domain containing 1(Dtwd1), and K177T in histi-
dine decarboxylase (Hdc) is not clear, despite the fact that they involve highly conserved amino
acids with charged side chains, and are predicted to be deleterious by both programs.
Some genes in the Aath4 interval differed significantly in expression levels in aorta and/or
peritoneal macrophages of parental 129S6 and DBA/2J wild type mice (S9 Table). The mRNA
levels in DBA aorta of Slc27a2, coding for a very long chain acyl-CoA synthase was only 20% of
those in 129 aorta. In contrast, expression in DBA aorta of EIA-like inhibitor of differentiation
1 (Eid1) and nephrocystin (Nphp1) were 180% and 130% of that in 129 aorta, respectively (S9
Table, P< 0.05).
We next searched for DBA/2J unique SNPs that are associated with variation of aortic gene
expressions in cis or in trans using the available eQTL data from Hybrid Mouse Diversity Panel
(HMDP) (S7 Table) [17]. In addition to Eid1 and Nphp1 described above, the presence of cis el-
ements controlling expression of Sppl2a, Dtwd1, Spef1 andMapre1 were suggested; although
the aortic expression in parental strains did not differ significantly except for the reduced ex-
pression of the gene coding for sperm flagellar protein 1 (Spef1) in DBA/2J. Genes that may be
controlled by the Ath4 locus in trans includedMtor on Chr 4, Cd24a on Chr 10 and Nub1 on
Chr 5, but none of these genes showed differential expression in the aorta or macrophages of
the parental strains.
Combining the human GWAS information, phenotypes of mouse mutants, and docu-
mented relevance to vascular health of each gene, we list 15 genes in the Aath4 intervals in
Table 3, which exhibit at least three of the six characteristics considered. Genes that exhibit at
least one of the characteristics are listed in S9 Table.
Functional SNPs in the Aath5 interval
The same strategy was applied to identify SNPs with potential relevance to the function of the
genes in the Aath5 interval. Among nonsynonymous SNPs (S6 Table), five of 15 substitutions
QTL for Early Atherosclerosis in Mouse Aortic Arch
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in Stabilin 2 (Stab2) of DBA were predicted to be deleterious: R151H, G864D and T1596M are
located in EGF-like domains and T382S and P1086L are in fasciclin domains. Nonsynonymous
SNPs in other genes were either 129 unique or predicted to be benign substitutions by
both programs.
Stab2 gene expression in the aorta was 18 fold higher in DBA than in B6 or 129 wild type
mice (Table 4). Its expression in peritoneal macrophages from DBA mice was also markedly el-
evated. Significant but small differences in aortic expression of DBA compared to 129 mice
were also observed for Nt5dc3 (140%) and Gnptab (80%). In addition, eQTL data on gene ex-
pression in aortic tissues from the HMDP identified associations of SNPs that are shared be-
tween 129 and B6 but differ in DBA. These included actin related protein 6 homolog (Actr6),
and histidine ammonia-lyase (Hal) on the same chromosome (S8 Table). Particularly notable
is the markedly low expression ofHal in both aorta (20% and 30%) and macrophage (10% and
5%) of DBA and B6 mice relative to the expression in 129 tissues. None of the genes whose ex-
pression was associated in trans with SNPs within Aath5 significantly differed in parental lines.
Nucleotide changes in non-coding exons could influence translation as well as the transcrip-
tion of a gene. For example, insulin like growth factor 1 (Igf1) is produced from multiple genes,
using alternative promoters and alternative splicing, which are translated and processed to pro-
duce identical Igf1 peptide of 70 amino acids [18]. There is a C to T change in the 5’UTR of
Igf1 in DBA, that results in an upstream AUG codon in some of the transcripts which could
lead to a premature start of translation, resulting in an out-of-frame protein. The significance
of this is not known, and plasma Igf1 levels in wild type 129 and DBA mice reported by Yuan
et al. are similar (260 ± 16 ng/ml in 129S1 females versus 248 ± 10 ng/ml in DBA/2J females;
320 ± 19 ng/ml in 129S1 males versus 285 ± 10 ng/ml in DBA2/J males) [19].
Taken together, we have picked 4 potential candidate genes in the Aath5 intervals exhibiting
at least three of the six characteristics considered (Table 4). Genes that exhibit at least two of
the characteristics are listed in S10 Table.
Stab2 genotype determines plasma hyaluronan levels
Since the above analysis suggested Stabilin 2 (Stab2) as the most potent candidate gene for
Aath5, we further examined whether allelic variations in the Stab2 protein of mice have effects
on its function. Stab2 is a scavenger receptor that recognizes multiple ligands, including hepa-
rin, acetylated LDL, apoptotic cells and advanced glycation end products; it is also the major re-
ceptor for the clearance of hyaluronan [20–23]. We first measured plasma hyaluronan in
129S6, C57BL/6J and DBA/2J inbred mice (Fig. 5A). Strikingly, plasma hyaluronan was 10
times higher in wild type DBA mice than in B6 or 129 mice (P< 0.0001). Moreover, in a subset
of the F2 population from the cross of DBA-apoE and 129-apoE mice, the hyaluronan levels
were significantly associated with the SNP genotype on Chr 10 near Stab2 (median values:
DBA/DBA, 542.4 μg/ml; hetero, 826.9 μg/ml; 129/129, 5535.1 μg/ml in males and DBA/DBA,
482.4μg/ml; hetero, 2155.7 μg/ml; 129/129, 4171.5 μg/ml in females) (Fig. 5B). Sex had a signif-
icant effect (P = 0.01) and linear regression tests revealed that the DBA allele had an additive ef-
fect. Plasma hyaluronan may also be regulated by its synthesis, degradation and interaction
with various receptors. However, no significant associations were observed in the same set of
animals between plasma hyaluronan levels and SNP genotypes near hyaluronane synthases,
Has1,Has2 andHas3; hyaluronidases, Hyal1–3; or receptors, Cd44, Lyve1 (lymphatic vessel en-
dothelial hyaluronan receptor 1) and Hmmr (hyaluronan mediated motility receptor)
(Fig. 5C).
Consistent with the previously demonstrated expression of Stab2 in liver sinusoidal endo-
thelial cells [24], examination of the expression of Stab2 in various tissues by real-time PCR
QTL for Early Atherosclerosis in Mouse Aortic Arch
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Fig 5. DBA-allele dependent upregulation of Stab2 and its ligand hyaluronan. (A) Plasma hyaluronan concentrations in the wild-type male C57BL/6,
129S6 and DBA2/J mice. Box-and-whisker plots: midline, median; box, 25th and 75th percentiles; whiskers, 1.5× interquartile range; dots, outliers. Numbers
of mice were indicated below the plots. (B) Plasma hyaluronan concentrations in a subset of F2 males and females of 129-apoE × DBA-apoE. Mice were
grouped by the genotype of rs13480630 on Chr 10, which is located near Stab2. Differences were compared by Kruskal–Wallis test followed by Steel-Dwass
test for (A) and (B). (C) Effects of other hyaluronan metabolic loci on plasma hyaluronan concentrations. The same set of F2 population was grouped into
129-homo, Hetero and DBA-homo according to the genotype of rs13459148 on Chr 17 (nearHas1), rs13482628 on Chr 15 (near Has2), rs3667255 on Chr 8
(near Has3), rs13480325 on Chr 9 (near Hayl1–3), rs13476631 on Chr 2 (near Cd44), rs13479497 on Chr 7 (near Lyve1) and rs13480973 on Chr 11 (near
Hmmr). Kruskal–Wallis test was used for the multiple comparison. (D) Expression levels of Stab2 in various tissues from B6 (black filled bars), 129 (gray filled
bars) and DBA (open bars). Data are relative to those in the B6 liver (= 100) assessed by quantitative RT-PCR. **P< 0.01, ***P< 0.001 vs. B6; ##P< 0.01,
###P< 0.001 vs. 129 (one-way ANOVA followed by Tukey-Kramer’s HSD test). Data were shown as the mean ± SD. Sample numbers were indicated in
the bars.
doi:10.1371/journal.pone.0117478.g005
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confirmed high mRNA levels for Stab2 in the liver, but strain difference in its liver expression
was not significant (Fig. 5D). In marked contrast, while Stab2 expression was very low in aorta,
heart, and kidneys of the B6 and 129 mice, the expression was approximately 10 times higher
in the respective DBA tissues (Fig. 5D). Since serum hyaluronan levels were associated with the
SNP near Stab2, and not in other loci related to synthesis or degradation of hyaluronan, it is
strongly suspected that hyaluronan clearance by Stab2 is reduced in DBA. However, elevated
mRNA of Stab2 in other tissues could compensate for local clearance of hyaluronan in DBA
mice, and may also influence binding of other ligands such as heparins, modified lipoproteins
and apoptotic cells. Taken together, these data support that Stab2 is an excellent candidate
gene for Aath5.
Discussion
In the present study, we identified two QTL, Aath4 and Aath5, which significantly affect ath-
erosclerotic plaque size in the aortic arch area by a cross between DBA-apoE and 129-apoE.
Overlap of Aath4 and Aath5 with other mouse QTL
The Aath4 on Chr 2: 127 Mb (CI: 123–148 Mb) is close to Ath45 on Chr 2: 162 Mb (CI: 157–
165 Mb) for aortic root plaque size that we previously identified in the same cross. DBA alleles
of both Aath4 and Ath45 associate with significantly larger plaque size than 129 alleles. Howev-
er, Ath45 was also detected in the cross between B6-apoE and 129-apoE, but QTL for aortic
arch atherosclerosis was absent in this region [10]. Consequently, although closely located, the
simplest inference is that the major candidate genes for Aath4 and Ath45 are distinct. We note,
however, that these QTL regions have not been narrowed sufficiently to eliminate the possibili-
ty that multiple genes are responsible for the observed phenotypic differences with some of the
genes affecting the size of plaques at both locations.
Other QTL previously mapped closely to Aath4 include Ath41 at 96 Mb (CI: 44–132 Mb)
between apoEKO mice on BALBc background and those on B6 background [25], Athla1 at
148 Mb (CI: 117–152 Mb) in (PERA × B6.129-Ldlr-/-) × B6.129-Ldlr-/- mice [26] and Ath28 at
179 Mb (CI: 174–179 Mb) from AKR.129-Apoe-/- × DBA/2.129- Apoe-/- mice [27]. B6 alleles of
these loci confer susceptibility to atherosclerotic plaques measured in the aortic root. There is a
possibility that Aath4 is the same as the QTL at 101 Mb previously identified as a determinant
of brachiocephalic artery plaque size in an F2 population between apoEKO mice on a C57BL/
6J and a C3H/HeJ (C3H) background and fed a western-type high fat diet [28]. Interestingly,
DBA mice share DNA variations with C3H mice within the 125–129 Mb interval, but not in
the 130–143 Mb interval. Thus this haplotype block of 125–129 Mb could be the primary can-
didate region, although one has to be cautious since diets differ between the two studies, and
Aath4 influences plaque size not only in the brachiocephalic artery but also within the aortic
arch, left carotid and left subclavian arteries (S3 Fig. and S3 Table).
While we found no significant effect of Aath5 on the root plaque size in neither the current
129-apoE × DBA-apoE cross, nor the root or arch plaque size in the previous B6-apoE × 129-
apoE cross, Aath5 overlaps with Ath17 [29] and Aorls1 [30] previously reported to affect diet-
induced aortic root atherosclerosis in B6 × 129 F2 females and in B6 × DBA/2 F2 females, re-
spectively. Unlike Aath5 in which the DBA-allele confers resistance to aortic arch atherosclero-
sis over the alleles in 129 and likely in B6, the DBA-allele of Aorls1 was associated with larger
plaques than the B6-allele. In addition, the B6-allele of Ath17 confers a dominant resistance to
atherosclerosis at the aortic root compared to the 129-allele. These data imply that Aath5 is
most likely a different locus from either Ath17 or Aorls1, unless the same locus affects athero-
sclerosis development differently in a gender-, diet-, or location-dependent manner.
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Candidate genes for Aath4 regulating inflammation
Several genes within the Aath4 interval have been demonstrated to have potential impacts on
early development of atherosclerosis. Histidine decarboxylase (Hdc) is a key enzyme for the
synthesis of histamine, an important inflammatory mediator. In addition to mast cells, entero-
chromaffin cells and neuroendocrine cells, the expression ofHdc has been detected in multiple
cell types including endothelial cells and macrophages. Histamine dilates micro-vessels and in-
creases the permeability of the capillaries to white blood cells and some proteins, while it causes
vasoconstriction of arteries and SMCmigration [31]. Hdc is present in atherosclerotic plaques
co-localizing with macrophages [32], and local production of histamine may also increase per-
meability to LDL and accelerate atherosclerotic plaque development. Consequently, the con-
cept that histamine stimulates chronic inflammatory conditions in atherosclerosis has long
been suspected. Supporting this view, both Hdc knockout mice and histamine receptor H1
knockout mice have been shown to develop smaller plaques in aorta when bred to apoEKO
mice [33,34]. As to mouse inbred strains, Martin et al. in 1984 described that renal protein lev-
els and enzymatic activities of Hdc in DBA/2J and C3H/HeJ mice are approximately 10 fold
higher than those in other strains including C57BL6/J [35]. Martin and Bulfield further ob-
served that the Hdc enzyme of DBA/2J binds the cofactor, pyridoxal-5’-phosphate, at a 2–3
fold higher Km than that of B6 [36]. These studies suggest that Hdc of DBA differs in both ex-
pression levels and protein structure from that of 129 and B6, possibly affecting histamine sig-
naling in local tissues.
Interestingly, the Aath4 interval also contains multiple genes, including Bcl2l11 (Bim),
Mertk, Siglec1 (Cd169) and Cd93, which are involved in apoptosis and/or clearance of apoptotic
cells. Efficient disposal of apoptotic cells (efferocytosis) is a crucial process in preventing cellu-
lar necrosis and release of intracellular molecules that potentially stimulate inflammation. In
early atherosclerosis, efferocytosis limits plaque development by suppressing further inflamma-
tory signaling events [37]. Mertk is a cell-surface receptor tyrosine kinase predominantly ex-
pressed in monocytic cells and functions to limit the extent of macrophage activation by
inducing secretion of anti-inflammatory molecules. In a mouse model with advanced athero-
sclerosis, Thorp and his colleagues demonstrated that kinase defectiveMertk promotes accu-
mulation of apoptotic cells and expansion of necrotic cores within plaques [38]. Further
investigation is required as to the functional consequence of nine amino acid differences be-
tween DBA and 129 proteins, three of which are predicted as potentially deleterious. CD93 was
originally identified as a B-cell marker, but is now known to be expressed in a wide variety of
cells including monocytes, activated macrophages and endothelial cells where it contributes to
cell adhesion and clearance of apoptotic cells. CD93 knockout mice exhibit an impaired uptake
of apoptotic cells in vivo [39]. The N268H substitution present in the first EGF-like domain of
CD93 of DBA/2J is also present in the CD93 of NOD (non-obese diabetic) mice; in NODmice
the CD93 locus is tightly linked to diabetic susceptibility, impaired leukocyte migration and in-
variant natural killer cell deficiency [40]. Together, our study suggests that Aath4 is likely to be
composed of multiple genes concertedly contributing to an increased inflammatory state and
accelerated atherosclerotic plaque formation in DBA-apoE mice relative to 129-apoE mice.
Stab2 as a candidate gene for Aath5
Knockout mice lacking Stab2 exhibit no specific phenotype except that they have elevated cir-
culating hyaluronan [41,42], though the effects of the lack of Stab2 on atherosclerosis has not
been evaluated. Hyaluronan is a primary constituent of the extracellular matrix and is also an
abundant component of atherosclerotic plaques. Hyaluronan binds to the active form of CD44
or HMMR and mediates leukocyte adhesion and extravasation, smooth muscle cell migration
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and neointimal proliferation following vascular injury, suggesting that it might promote ath-
erosclerotic plaque development [43]. Consistent with this view, Chai et al. showed that
smooth muscle-specific over-expression of hyaluronan promotes the development of aortic
atherosclerosis in apoEKOmice [44]. However, the contribution of hyaluronan to atheroscle-
rosis may well be context-dependent, since hyaluronan provides viscoelastic properties to the
vasculature and forms the endothelial glycocalyx, which provides protection from leukocyte
adhesion. Similarly, hyaluronan can also significantly inhibit PDGF-BB-induced VSMC prolif-
eration in culture in a dose dependent manner [45]. Nagy et al. have shown that pharmacologi-
cal inhibition of hyaluronan synthesis accelerates plaque development in apoEKO mice, and
that the increased atherosclerosis was accompanied by the reduced endothelial glycocalyx, en-
dothelial dysfunction and increased prothrombotic states of the treated animals [46]. Further-
more, in cholesterol fed rabbits, Ferns et al. showed that the administration of hyaluronan
significantly reduced intima-medial ratio after balloon injury; this was associated with reduced
neointimal macrophage influx [47]. These observations support a possibility that the 10 times
elevation of plasma hyaluronan levels is due to decreased catabolism by Stab2; this could ac-
count for the protective effects of DBA-Aath5 on early plaque formation. However, hyaluronan
is only one of many Stab2 ligands, and the effects of DBA-Stab2 on clearance of other ligands
in vivomust be examined, since hyaluronan binding site does not appear to overlap with sites
for heparin or acetylated LDL [48]. Marked increase in Stab2 gene expression in aorta, macro-
phage and heart of DBA mice also indicate that local hyaluronan clearance may well be com-
pensated for, and/or even result in an increased clearance of some other molecules thereby
regulating local signaling. Clearly, further studies are necessary and we are in the process of
generating congenic lines that carry the DBA allele of Stab2 and nearby genes on the back-
ground of 129-apoE as a first step.
Conclusions
Our QTL analysis of the cross between DBA-apoE and 129-apoE mice has identified two new
loci, Aath4 on Chr 2 and Aath5 on Chr 10 that affect arch plaque development. Together with
Aath1 and Aath2 on Chr 1 and Aath3 on Chr 15, which were detected in our previous QTL
analysis of a cross between B6-apoE and 129-apoE mice, there are at least five loci for arch pla-
que size involving 129-apoE mice. The genetic loci affecting root plaque size and arch plaque
size are clearly discrete, suggesting that the pathological processes underling plaque develop-
ment at the aortic arch are distinct from those at the aortic root. Our best candidate genes,
Hdc,Mertk and Cd93 for Aath4 and Stab2 for Aath5, all play pivotal roles in early processes of
atherosclerosis by regulating leukocyte recruitment, macrophage activation, and inflammation.
However, these processes must be common to plaque development at all vascular locations,
and the major question why they appear to play roles in the development of plaques in the aor-
tic arch but not in the aortic root remains to be answered. Differences in the local responses to
these circulating factors at different vascular locations as well as the expressions of these factors
within the cells in different vascular beds require further attention in future studies. Addition-
ally, both Aath4 and Aath5 contain multiple potent candidates whose involvements in athero-
genesis are worthy of investigation.
Materials and Methods
Animals
apoEKOmice on a 129S6/SvEvTac genetic background (129-apoE) were generated in our labo-
ratory as previously described [9]. apoEKOmice on a DBA/2J background (DBA-apoE) were
obtained from Jackson Laboratory (#007067, D2.129P2(B6)-Apoetm1Unc/J). Male 129-apoE
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mice were mated to female DBA-apoE mice to generate F1 hybrids, which were intercrossed to
generate F2 progeny [11]. Mice were fed regular mouse chow (Prolab IsoPro RMH 3000;
Agway Inc) and handled under protocols approved by the Institutional Animal Care and Use
Committees of the University of North Carolina at Chapel Hill (Protocol Number: 11–028).
For euthanasia and tissue harvest, mice were fully anesthetized by inhalation of isoflurane or
CO2 and immediately sacrificed by cervical dislocation. For atherosclerosis plaque size mea-
surement, mice were anesthetized with an overdose of 2’2’2’-triethanol prior to perfusion of
aortic trees through the heart with buffered 4% paraformaldehyde.
Phenotyping
Atherosclerotic plaque size at the aortic arch was measured as previously described [10]. Brief-
ly, mice at 4 months of age were perfused with 4% paraformaldehyde. Aorta with branch ves-
sels were dissected, cleared of fat tissues, then imaged; after which atherosclerotic lesions were
measured on the captured images using Image J 1.43 software (http://rsb.info.nih.gov/ij/) [10].
DNA isolation and genotyping
Genomic DNA was isolated from livers and purified using DNeasy Tissue Kit (Qiagen, Hilden,
Germany), followed by quantification using PicoGreen dsDNA Assay Kit (Molecular Probes,
Eugene OR, USA). Single nucleotide polymorphism (SNP) genotyping was performed using
Illumina BeadArray technology with Mouse Low Density Linkage SNP panels, which is an op-
timized set of 377 SNPs covering the 19 autosomes and the X chromosome and includes ap-
proximately four SNPs per each 27 Mb interval across the entire mouse genome.
QTL analysis
QTL analyses were performed using R/qtl (v.1.24–9, http://churchill.jax.org/software/
jQTLhtml) [49,50]. Square root-transformation was applied to aortic lesion size to obtain nor-
mal distribution. The main effect QTL were identified by genome-wide single-QTL scans using
the ‘scanone’ function with standard interval mapping. Genotype probabilities between mark-
ers were computed with 1 cM intervals and with a genotyping error rate of 0.001. The signifi-
cance thresholds were determined by 10,000 permutations. QTL were considered significant if
LOD scores exceeded 95% (P< 0.05) of the permutation distribution; they were considered
suggestive if the scores exceed 37% (P< 0.63) distribution. 95% confidence intervals (CIs) for
QTL positions were calculated by Bayesian credible interval function of the software. To deter-
mine sex-specific QTL, main scans were performed with sex as an additive covariate or as an
interactive covariate. We also performed QTL analysis in males and females separately. The
presence of two QTL on the same chromosome was assessed by comparing two models: a
model with one QTL and a model with both QTL. If the LOD score difference (ΔLOD) was
greater than 2, two QTL were considered to be present on the same chromosome. For each
QTL, model of inheritance was determined according to allelic effect at the nearest marker of a
QTL by performing linear regression using the additive and dominant/recessive models.
Multiple-QTL models were detected by the ‘stepwiseqtl’ function of R/qtl, which perform a
forward/backward stepwise search algorithm to select the best-fitting model. Penalties for the
model comparison corresponding to α = 0.1 were calculated using the result of 1,000 permuta-
tions with the ‘scantwo’ function. The proportion of variance and LOD score under the model
was calculated using the ‘fitqtl’ function. A multiple imputation was used for the analyses. All
the genetic positions (cM) were converted to physical positions (Mb, NCBI Build 37) using the
Mouse Map Converter (http://cgd.jax.org/mousemapconverter/).
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Microarray analysis
Aortas were dissected from 3- to 5-month-old wild type male mice. Peritoneal macrophages
were isolated from 3-month-old mice of both sexes 4 days after the intraperitoneal injection of
1 ml thioglycollate. For each sample, tissues/macrophages from 4–5 mice were pooled and total
RNA was extracted. For each strain, 129S6, C57BL/6J and DBA/2J, three aortic samples and
one male and one female macrophage samples were subjected to Affymetrix chip analysis.
Data was deposited to Gene Expression Omnibus (GEO) Database (accession number
GSE53006) [11].
Comparative genomics and haplotype analysis
Haplotype patterns of genomes in the QTL interval were analyzed using UNCMouse Phyloge-
ny Viewer (http://msub.csbio.unc.edu/) and Perlegen Mouse SNP Browser (http://mouse.cs.
ucla.edu/perlegen/). SNPs and nucleotide sequence comparisons of mouse strains were ob-
tained from publicly available resources (http://www.sanger.ac.uk/resources/mouse/genomes/,
http://useast.ensembl.org /Mus_musculus/, and http://www.informatics.jax.org/). Sanger Ge-
nome Project includes whole genome sequence of 129S1 and 129S5 but not 129S6. We used
129S5 sequence to represent 129S6 sequence in our comparisons since they are very closely re-
lated [51]. The following characteristics were searched: (1) nonsynonymous SNPs with poten-
tially damaging effects on protein structure and functions, (2) Genes expressed in aorta and/or
peritoneal macrophages of parental C57BL6/J, DBA/2J and 129S6 wild-type mice, and differ
among the strains, (3) SNPs associated with variation of gene expressions in cis or in trans. Ad-
ditionally, (4) information from human GWAS, (5) phenotypes of knockout mice and (6) doc-
umented relevance to vascular health, were considered. The likelihood that an amino acid
change is detrimental to a protein was examined by Sorting Intolerant From Tolerant (SIFT)
program (http://sift.jcvi.org/) [14] and Polymorphism Phenotyping v2 (PolyPhen-2) program
(http://genetics.bwh.harvard.edu/pph2/) [15]. Gene expression data in the aorta of mice in the
Hybrid Mouse Diversity Panel (HMDP) was obtained from GEO Database (accession number
GSE38120) [17]. SNPs were selected from the eQTL data of the HMDP according to the fol-
lowing criteria: (1) location within and near the QTL interval, (2) being associated with genes
at P< 1.0 × 10-6, and (3) having nucleotide sharing pattern of DBA 6¼ 129 = B6. Clusters of
linked SNPs are represented by one with smallest P value, followed by the shortest distance to
the start of the gene when it is on the same chromosome. All the genomic locations are in Mb.
Information of human GWAS data was obtained from NHGRI GWAS catalog (http://www.
genome.gov/gwastudies/).
Plasma hyaluronan analysis
Plasma hyaluronan concentration was measured by Hyaluronan Quantikine ELISA Kit (R&D
Systems, Minneapolis, MN) according to the manufacturer’s protocol. Plasma samples were di-
luted 1/40 to 1/150.
RT-PCR
Tissues were dissected from 3-month-old male mice and stored in RNAlater solution (Life
Technologies, Carlsbad, CA). Total RNA was isolated using an ABI 6700 Automated Nucleic
Acid Workstation (Applied Biosystems, Foster City, CA), and real-time quantitative RT-PCR
was performed by an ABI prism 7700 sequence detection system (Applied Biosystems, Foster
City, CA). The primer/probe sequences for Stab2 were: CAGCAAGTTGATACAGGACTC
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(forward), TAGGCCAGAAGAGAGTGACT (reverse), and CTTGCTGAAAGTCATCACT-
GACCCCA (probe). Stab2mRNA level in each samples was normalized to that of β-actin.
Statistical analysis
Data were analyzed using JMP software version 8.0 (SAS Institute, Cary, NC). Comparisons of
multiple groups in trait values and gene expression levels were done by one-way analysis of var-
iance (ANOVA) followed by Tukey-Kramer’s HSD test. For the analysis of SNPs and plasma
hyaluronan levels, nonparametric Kruskal–Wallis (Rank-sum) test followed by Steel-Dwass
test was used.
Supporting Information
S1 Fig. Correlations between root plaque size and plasma lipids. (A) Body weight in the pa-
rental 129-apoE and DBA-apoE, F1, and F2 mice. Box-and-whisker plots: midline, median;
box, 25th and 75th percentiles; whiskers, 1.5× interquartile range; dots, outliers. (B–D) Correla-
tions between body weight and arch plaque size (B and C) or root plaque size (D and E) in F2
males (B and D) and females (C and E). Plaque size was transformed to square root (sqrt).
(TIF)
S2 Fig. Correlations between root plaque size and plasma lipids. Correlations of arch plaque
size with total cholesterol, high-density lipoprotein (HDL) cholesterol and triglyceride in F2
males and females.
(TIF)
S3 Fig. LOD curves for atherosclerotic plaque size at branches of the aortic arch. LOD
curves for the lesion size at brachiocephalic artery (BCA), left common carotid artery (LCCA),
left subclavian artery (LSCA) and total arch (sum of the lesions at the aortic arch and at all the
branches) with sex as an interactive covariate. X-axis represents chromosome number and y-
axis represents the LOD score. The horizontal dashed lines represent the thresholds for signifi-
cant QTL (P = 0.05) and suggestive QTL (P = 0.63).
(TIF)
S1 Table. Atherosclerotic plaque size at branches of aortic arch in the parental, F1, and F2
mice. BCA, brachiocephalic artery; LCCA, left common carotid artery; LSCA, left subclavian
artery. Total arch is sum of plaques at the aortic arch and in BCA, LCCA and LSCA branches.
Data are shown as the mean ± SD (× 104 μm2). P< 0.001 vs. 129-apoE mice within each
sex. ††P< 0.01 vs. male mice within the strain.
(DOC)
S2 Table. Normality tests for arch plaque distribution. Distributions of arch plaque size were
examined for normality by Shapiro-Wilk test before and after the square root-transformation.
Null hypothesis that the data are normally distributed is not rejected when square root-trans-
formation is applied.
(DOC)
S3 Table. QTL for atherosclerosis at branches of aortic arch identified by genome-wide sin-
gle scan. QTL detected by genome-wide single scan using sex as an interactive covariate are
shown. % Variance shows the percentage of the total F2 phenotypic variance. Significant QTL
are shown in bold letters. CI, 95% confidence interval. BCA, brachiocephalic artery; LCCA, left
common carotid artery; LSCA, left subclavian artery; Total arch, sum of plaques in the Aortic
arch, BCA, LCCA and LSCA.
(DOC)
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S4 Table. Multiple regression analyses for arch lesion in the F2 mice. df, degree of freedom;
% Variance shows the percentage of the total F2 phenotypic variance.
(DOC)
S5 Table. Estimated effects of amino acid substitutions in Aath4 candidates. Effects of each
amino acid substitutions in mouse proteins were predicted by SIFT (Sorting Intolerant From
Tolerant) program [14]. SIFT scores show the probability that an amino acid change is damag-
ing with a score of 0 to 1. AA substitutions with SIFT score0.05 were predicted to be deleteri-
ous; substitutions with SIFT score>0.05 to be tolerated. Effects of substitutions of the residues
at the equivalent position in human proteins to residues in mouse proteins were predicted by
PolyPhen-2 (Polymorphism Phenotyping v2) program [15]. Where the residue in human pro-
tein differs from mouse protein, effects of substitution to both 129-type and DBA-type amino
acids (shown in parentheses) were examined. PolyPhen-2 shows the probability that a muta-
tion is damaging, ranging from 0 (benign) to 1 (damaging).----indicates no equivalent residue
is present in human protein. Deleterious changes were shown in bold.
(DOC)
S6 Table. Estimated effects of amino acid substitutions in Aath5 candidates. Effects of each
amino acid substitutions in mouse proteins were predicted by SIFT (Sorting Intolerant From Tol-
erant) program [14]. SIFT scores show the probability that an amino acid change is damaging
with a score of 0 to 1. AA substitutions with SIFT score0.05 were predicted to be deleterious;
substitutions with SIFT score>0.05 to be tolerated. Effects of substitutions in human proteins at
the equivalent residue were predicted by PolyPhen-2 (Polymorphism Phenotyping v2) program
[15]. Where the residue in human protein differs from those in mice, effects of substitutions to
both 129-type and DBA-type were examined. PolyPhen-2 shows the probability that a mutation
is damaging, ranging from 0 (benign) to 1 (damaging). Deleterious changes were shown in bold.
(DOC)
S7 Table. SNPs within the Aath4 interval associated with gene expressions in the aorta
from Hybrid Mouse Diversity Panel. Representative SNPs within and near the 123–148 Mb
of Chr 2 that meet the criteria of 129 = B6 6¼ DBA and P< 1.0 × 105 were selected from the
eQTL data from the Hybrid Mouse Diversity Panel (HMDP) [17]. (-) or (+) in front of the dis-
tance indicates the position of the SNP is 5’ or 3’ respectively to the start of the gene. “trans” in-
dicates the associated gene is on different chromosome. For each SNP, expression levels of the
associated genes in the aorta (A) and macrophages (M) estimated by microarray analyses of
the wild-type B6 and DBA strains relative to the expression of the 129 mice and the signal val-
ues of 129 expression are shown.
(DOC)
S8 Table. SNPs within the Aath5 interval associated with gene expressions in the aorta
from Hybrid Mouse Diversity Panel. Representative SNPs within and near the 30–101 Mb in-
tervals of Chr 10 and associated genes that meet the criteria of 129 = B6 6¼ DBA and P< 1.0 × 105
were selected from the eQTL data from the Hybrid Mouse Diversity Panel (HMDP) [17]. For
each SNP, expression levels of associated genes in the aorta (A) and macrophages (M) estimat-
ed by microarray analyses of the wild-type 129, B6 and DBA strains were indicated.
(DOC)
S9 Table. Haplotype analysis of Aath4 on Chr 2. Genes with DBA-unique sequences (DBA 6¼
B6, 129) within and near the interval of 123–148 Mb are shown. For each gene, expression ra-
tios in the aorta and macrophages, expression levels in 129, amino acid (AA) differences (B6,
129-position-DBA), associations with atherosclerosis indicated by GWAS data, and
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phenotypes of knockout or mutant mice are shown. Ratios between two strains that show sig-
nificant difference in the expression are bolded. AA substitutions that are predicted to be dele-
terious by SIFT and/or Polyphen2 programs are bolded (see S5 Table). aP< 0.05.
(DOC)
S10 Table. Haplotype analysis of Aath5 on Chr 10. Genes with DBA-unique sequences
(DBA 6¼ B6, 129) within and near the interval of 30–101 Mb are shown. For each gene, expres-
sion ratios in the aorta and macrophages, expression levels in 129, amino acid (AA) differences
(B6, 129-position-DBA), associations with atherosclerosis indicated by GWAS data, and pheno-
types of knockout or mutant mice are shown. Ratios between two strains that show significant
difference in the expression are bolded. AA substitutions that are predicted to be deleterious by
SIFT and/or Polyphen2 programs are bolded (see S6 Table). aP< 0.05, bP< 0.01, cP< 0.001.
(DOC)
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